Mr. Xin Huang|Oncology Pharmaceuticals|Best Researcher Award

Mr. Xin Huang|Oncology Pharmaceuticals|Best Researcher Award

Mr. Xin Huang at Wuhan union hospital,China

PROFILE  

 

scopus

Orcid

Early Academic Pursuits 🎓

Dr. Xin Huang’s academic journey commenced at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, where their dedication to medical and research excellence became evident. Since September 2017, Dr. Huang has pursued a dual degree (M.D., Ph.D.), focusing on the nexus of clinical medicine and groundbreaking research. This rigorous training honed both clinical acumen and investigative prowess, laying the foundation for significant contributions to medical science. Their education encompassed advanced studies in bone and joint diseases, immune inflammation, and regenerative medicine, highlighting a strong commitment to tackling some of the most pressing challenges in healthcare.

Professional Endeavors 🩺

Dr. Xin Huang is currently an Attending Doctor at Union Hospital, Tongji Medical College. In this capacity, they seamlessly integrate patient care with research innovation. Beyond clinical practice, Dr. Huang has contributed to over 38 peer-reviewed publications in high-impact journals, reflecting a commitment to advancing medical knowledge.

Their professional engagements also include editorial roles on the Young Editorial Boards of journals like iMeta, Biomaterials Translational, and Gene Expression. These roles underscore their expertise and standing in the scientific community. Furthermore, Dr. Huang has expanded their horizons internationally through a visiting study at the University of Würzburg, Germany, fostering global collaboration in cutting-edge research.

Contributions and Research Focus 🔬

Dr. Huang’s research portfolio is both diverse and impactful. Their primary focus lies in targeted and precise treatment of bone tumors, particularly through an innovative approach centered on the tumor microenvironment (TME). Key areas of research include:

  • Tumor Microenvironment Exploration: Revealing the characteristics of the TME in bone tumors to understand how these environments support or hinder disease progression.
  • Immune Checkpoint Studies: Investigating immune checkpoints such as PD-L1 to discover how they can be manipulated for therapeutic purposes, especially in immunotherapy.
  • Biomimetic Nanovesicles: Pioneering the construction of biomimetic cell membrane-coated nanovesicles designed to deliver targeted anti-tumor treatments with high precision and minimal side effects.

This work has contributed to new paradigms in treating bone tumors and has significant implications for broader applications in oncology, regenerative medicine, and immunology.

Accolades and Recognition 🏆

Dr. Xin Huang’s dedication to research and patient care has been widely recognized. With 38 SCI/Scopus-indexed publications and three patents, Dr. Huang has firmly established themselves as a thought leader in their field. Their editorial appointments and membership in prestigious organizations such as the Chinese Medical Doctor Association and the Tumor Precision Therapy Professional Committee of the Chinese Anti-Cancer Association further attest to their standing in the academic and medical community.

Notably, Dr. Huang is a nominee for the Best Researcher Award, a testament to their relentless pursuit of excellence and innovation.

Impact and Influence 🌟

Dr. Huang’s work transcends academic circles, offering tangible benefits for patients and practitioners alike. By revealing the intricacies of the tumor microenvironment and advancing targeted treatments, they have paved the way for more effective therapies with fewer side effects.

Their contributions have also fostered international collaboration, bridging the gap between research communities in China and Europe. As an advocate for interdisciplinary research, Dr. Huang’s efforts have influenced emerging areas such as nanomedicine, tissue engineering, and immune-oncology.

Legacy and Future Contributions 🌍

Dr. Xin Huang’s legacy is one of innovation, compassion, and collaboration. As they continue their work in regenerative medicine and oncology, their future goals include:

  • Expanding Clinical Applications: Translating research findings into widely accessible treatments for bone tumors and related conditions.
  • Mentorship and Leadership: Inspiring the next generation of scientists and clinicians by serving as a mentor and role model.
  • Global Health Initiatives: Extending their expertise to address global health challenges, particularly in under-resourced settings.

In summary, Dr. Xin Huang’s journey is characterized by a commitment to excellence in medicine and science. Through their pioneering research, professional dedication, and collaborative spirit, they are poised to leave an enduring impact on the fields of oncology, regenerative medicine, and beyond.

🎓Publication 

Injectable hydrogels for Fenton-like Mn2+/Fe2+ delivery with enhanced chemodynamic therapy prevent osteosarcoma recurrence and promote wound healing after excision surgery

  • Authors   :Wang, L., Guo, H., Zhang, W., Su, Z., Huang, X.
  • Journal    : Materials Today Bio
  • Year         :2024

Overcoming T Cell Exhaustion in Tumor Microenvironment via Immune Checkpoint Modulation with Nano-Delivery Systems for Enhanced Immunotherapy

    • Authors   : Huang, X., Zhang, W.
    • Journal    :Small Methods
    • Year         :2024

Macrophage membrane-camouflaged biomimetic nanovesicles for targeted treatment of arthritis

  • Authors   : Huang, X., Zhang, W.
  • Journal    : Ageing Research Reviews
  • Year         :2024

The generation and use of animal models of osteosarcoma in cancer research

  • Authors   : Pu, F., Guo, H., Shi, D., Zhang, Z., Shao, Z.
  • Journal     : Genes and Diseases
  • Year         :2024

Bioinspired nanovesicles released from injectable hydrogels facilitate diabetic wound healing by regulating macrophage polarization and endothelial cell dysfunction

  • Authors   : Zhang, W., Yang, X., Huang, X., Chen, L.
  • Journal    : Journal of Nanobiotechnology
  • Year         :2023

Assist Prof Dr. Ali Tavakoli|Oncology Pharmaceuticals|Best Researcher Award-1234

Assist Prof Dr. Ali Tavakoli,Oncology Pharmaceutical,Best Researcher Award

Assist Prof Dr. Ali Tavakoli, at Shiraz University of Medical Sciences,Iran

PROFILE

GOOLE scholar

🎓Early Academic Pursuits :

Dr. Ali Tavakoli embarked on his distinguished academic journey by earning his Medical Doctor (MD) degree from Shiraz University of Medical Sciences in Shiraz, Iran, in 1998. His early academic pursuits were marked by a profound interest in the complexities of the human body and the desire to contribute to medical science. This foundational phase was not just about acquiring knowledge but also about laying the groundwork for a career dedicated to improving health outcomes.

He continued his academic journey with a Master in Public Health (MPH) from the same institution in 2007. His MPH thesis, which focused on investigating risk factors of low birth weight in newborns, underlined his commitment to addressing public health issues. The meticulous work conducted under the supervision of Dr. Mohammad Hadi Imanieh showcased his analytical skills and dedication to maternal and child health.

🩺Professional Endeavors :

Dr. Tavakoli’s professional career has been a blend of clinical practice, administrative roles, and academic contributions. As an Assistant Professor in the Department of Persian Medicine at Shiraz University of Medical Sciences, he has been instrumental in advancing the field of traditional medicine. His role involves not only teaching but also mentoring students and conducting groundbreaking research.

Between May 2020 and November 2021, he served as the Advisor to the Chancellor of Shiraz University of Medical Sciences, a role that emphasized his leadership and strategic planning abilities. His involvement in significant projects, such as the national food security project in Zarrin Dasht County and the national MMR vaccination project, highlights his dedication to public health initiatives.

📚Contributions and Research Focus :

Dr. Tavakoli’s research has significantly contributed to various fields, including traditional Persian medicine, public health, and clinical trials. His Ph.D. thesis, supervised by Dr. Seyed Alireza Taghavi, evaluated the effect of Rose (Rosa damascena mill L) Oil Soft Capsules on clinical outcomes in ulcerative colitis, showcasing his innovative approach to integrating traditional remedies with modern clinical practices.

His extensive list of publications, including studies on the quality of work life and human resource productivity, the effects of medicinal plants on clinical conditions, and the efficacy of traditional treatments, reflects his diverse research interests and his ability to bridge traditional and modern medicine. Notable publications include:

  • “Efficacy of Rose Oil Soft Capsules on Clinical Outcomes in Ulcerative Colitis: A Pilot Randomized, Double-Blinded, Placebo-Controlled Clinical Trial” (Galen Medical Journal, 2019)
  • “COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study” (Iranian Journal of Medical Sciences, 2023)
  • “Efficacy of Plantago major leaf extract cream in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial” (European Journal of Integrative Medicine, 2023)

🏆Accolades and Recognition :

Dr. Tavakoli’s excellence has been recognized through various awards and honors. He was the top student in the Traditional Persian Medicine Ph.D. comprehensive exam at Shiraz University of Medical Sciences in 2014 and the top Ph.D. graduate in 2012. In 2010, he was awarded as the Annual Best Staff at Shiraz University of Medical Sciences, reflecting his outstanding contributions to the institution.

🌟Impact and Influence :

Dr. Tavakoli has had a profound impact on both his students and the broader medical community. His leadership roles, such as being a member of the Executive Committee of the Shiraz International mHealth Congress and his involvement with the Iranian Scientific Association of Traditional Medicine, have allowed him to influence the direction of medical research and public health policies.

🌍Legacy and Future Contributions :

Dr. Tavakoli’s legacy is characterized by his commitment to integrating traditional Persian medicine with contemporary clinical practices. His work has paved the way for future research in this field, promoting a holistic approach to healthcare. His ongoing research and publications continue to influence and inspire new generations of medical professionals.

In the future, Dr. Tavakoli aims to expand his research into the global applications of traditional Persian medicine, contributing to international medical knowledge and practices. His dedication to education, research, and public health ensures that his contributions will have a lasting impact on the medical community and beyond.

🎓Publication 

Reporting of adverse effects of pomegranate in clinical studies: a systematic review

  • Authors   :Hamid Zare, Ehsan Amiri Ardekani, Ali Tavakoli, Ryan Bradley, Fatemeh Tavakoli, Mehdi Pasalar
  • Journal    :Journal of Complementary and Integrative Medicine
  • Year         : 2024

Radiodermatitis in the field of traditional Persian medicine; a narrative review

    • Authors :Ghazaleh Heydarirad, Bahareh Ahadi, Ali Tavakoli, Hamid Reza Mirzaei, Mojgan Mehri Ardestani, Shaghayegh Kamian, Mehdi Pasalar
    • Journal   :Annals of the Romanian Society for Cell Biology
    • Year       : 2021

World Congress Integrative Medicine & Health 2017: part two: Berlin, Germany. 3–5 May 2017

  • Authors  :, Kyung-Eun Choi, Lisha He, Han Wang, X He, C Gu, Y Zhang, Linhua Zhao, Xiaolin Tong, Lisha He, Han Wang, Xinhui He, Chengjuan Gu, Ying Zhang, Linhua Zhao, Xiaolin Tong, Lisha He
  • Journal    :BMC Complementary and Alternative Medicine
  • Year         :  2017

Efficacy of Plantago major leaf extract cream compared to placebo in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial

  • Authors  :Zahra Salehi, Ali Tavakoli, Seyed Hassan Hamedi, Soodabeh Samimi, Foroogh Namjooyan, Mansour Ansari, Hamid Nasrollahi, Nezhat Khanjani, Niloofar Ahmadloo, Ahmad Mosalaei, Behnam Kadkhodaei, Hossein Molavi Vardanjani, Mehrab Sayadi
  • Journal   :European Journal of Integrative Medicine
  • Year        :   2023

 

Impact of Jollab on Blood Parameters in Patients with Breast Cancer Undergoing Chemotherapy: A Pilot Randomized Controlled Trial

  • Authors  :Ghazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali TavakoliGhazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali Tavakoli
  • Journal   :Galen Medical Journal
  • Year        :   2021